Skip to main content
SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD logo

SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002737 ISIN · CNE100001WT7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,262 across all filing types
Latest filing 2023-12-08 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002737

About SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD

https://www.kuihuayaoye.com

Sunflower Pharmaceutical Group Co., Ltd. focuses on the research, development, manufacturing, and distribution of proprietary Chinese medicines, chemical drugs, and health supplements. The organization is particularly noted for its specialization in pediatric medicine, marketed under the "Little Sunflower" brand, which includes treatments for respiratory and digestive ailments. Its extensive product portfolio also covers gynecological health and general internal medicine. The group operates several integrated production bases and research institutes, facilitating a comprehensive approach to drug formulation and quality control. By leveraging a robust supply chain and a wide-reaching distribution network, the company provides a diverse range of over-the-counter and prescription solutions aimed at improving family health and wellness.

Recent filings

Filing Released Lang Actions
关于续聘会计师事务所的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the company's intention to reappoint an accounting firm (立信会计师事务所) as the auditor for the 2023 fiscal year. It details the auditor's qualifications, past performance, fees, and the approval process by the board and audit committee. There is no actual audit report or financial statements included, nor is there detailed financial data or analysis. The document is a formal announcement of the auditor reappointment proposal to be approved by the shareholders. The document length is 4308 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this document fits best under the category of Audit Report / Information (AR) as it relates to audit matters but is not a full annual report or audit report itself. However, since it is an announcement of the auditor reappointment and not the audit report itself, it is more appropriate to classify it as Regulatory Filings (RNS) because it does not contain the audit report or financial statements but is a regulatory announcement about audit firm appointment.
2023-12-08 Chinese
独立董事工作制度（2023年12月）
Governance Information Classification · 95% confidence The document is titled '独立董事工作制度' which translates to 'Independent Director Work System' and details the governance structure, qualifications, duties, nomination, election, and responsibilities of independent directors at the company. It references relevant laws, regulations, and stock exchange rules governing independent directors. The content is a governance framework document rather than a financial report, earnings release, or announcement. It does not contain financial data, audit results, or voting results. It is a governance-related policy document outlining internal rules and practices for independent directors. Therefore, it fits best under the category of Governance Information (CGR). The document length (8203 characters) and detailed content support this classification with high confidence.
2023-12-08 Chinese
第四届监事会第二十一次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of a resolution passed at the 21st meeting of the 4th Supervisory Board of the company. It details the approval to renew the appointment of the auditing firm for the 2023 fiscal year, including audit fees and the need for shareholder approval. The document is short (833 characters) and serves as a meeting resolution announcement rather than the audit report itself. It does not contain any financial statements or detailed audit results. Therefore, it is not an Audit Report (AR) but rather a Regulatory Filing (RNS) as it is a formal regulatory announcement about audit firm appointment and related procedural matters.
2023-12-08 Chinese
关于第四届董事会、监事会延期换届的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the postponement of the board of directors and supervisory board re-election. It discusses governance continuity and the extension of the current board's term. There is no financial data, no mention of annual or quarterly reports, no audit information, and no regulatory filings beyond this governance update. The content clearly relates to board/management information about changes or delays in board elections. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and focused solely on this governance matter, confirming the classification.
2023-12-08 Chinese
独立董事关于第四届董事会第二十八次会议相关事项的独立意见
Audit Report / Information Classification · 95% confidence The document is an independent director's opinion regarding the reappointment of an audit firm for the company's 2023 annual audit. It references compliance with company law, stock exchange listing rules, and internal governance. The content focuses on the approval and endorsement of the audit firm and related procedures, not the audit report itself. The document length is short (589 characters), and it serves as a formal opinion or statement related to audit matters rather than a full audit report or annual report. Therefore, it fits best under Audit Report / Information (AR), which includes standalone audit-related opinions and information excluding full annual reports. FY 2023
2023-12-08 Chinese
第四届董事会第二十八次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of the resolutions passed at the 28th meeting of the 4th Board of Directors of the company. It details the meeting date, attendance, agenda items, voting results, and mentions that certain matters will be submitted to the shareholders' meeting for approval. The content focuses on board decisions such as the reappointment of the audit firm and amendments to internal governance documents. There is no financial data, earnings information, or detailed report content. The document is clearly a board meeting resolution announcement, which fits the category of Board/Management Information (MANG). The document length is short (1277 characters), and it is not an announcement of a report publication but a substantive announcement of board decisions.
2023-12-08 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.